Csenge Advisory Group »

Predictive Oncology shares owned by Csenge Advisory Group

Quarter-by-quarter ownership of Predictive Oncology (POAI) shares owned by Csenge Advisory Group from 13F filings

Historical chart of Csenge Advisory Group investment in Predictive Oncology

Tip: Access up to 7 years of quarterly data

All positions including Predictive Oncology held by Csenge Advisory Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Predictive Oncology by Csenge Advisory Group

Quarter filed Position value Share count Share price at filing
2024-09-30 $8.0k 13k 0.61

More positions owned by Csenge Advisory Group

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
First Tr Morningstar Divid L SHS (FDL)
First Tr Exchange-traded First Tr Enh New (FTSM)
First Tr Exchange-traded Risng Divd Achiv (RDVY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
First Tr Exchange-traded Fst Low Oppt Eft (LMBS)
NVIDIA Corporation (NVDA)
First Tr Exchange-traded Limited Duration (FSIG)
First Tr Exchng Traded Fd Vi Tcw Unconstrai (UCON)
Spdr Gold Tr Gold Shs (GLD)
Microsoft Corporation (MSFT)
Ishares Tr S&p 500 Grwt Etf (IVW)
Ishares Tr Hdg Msci Eafe (HEFA)

View all positions for Csenge Advisory Group

Top funds holding Predictive Oncology

Vanguard Group
Geode Capital Management
Susquehanna International
State Street Corporation
Csenge Advisory Group
Carnegie Mellon University
Tower Research Capital
Wells Fargo & Company
Advisor Group Holdings
PSI Advisors
National Bank Of Canada /fi/
Bank of America Corporation
Royal Bank of Canada

View all funds holding Predictive Oncology